By showing that FNDC5/irisin is an importantmediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisinas a novel agent capable of opposing synapse failure and memory impairment in AD. This evidence concerns the gene FNDC5 and Alzheimer disease.